MIGNOGNA, MICHELE DAVIDE
MIGNOGNA, MICHELE DAVIDE
Comment on “Toward ICHD-4: Proposing a broader diagnostic framework for burning mouth syndrome” by Suga et al., 2025
2025-01-01 Musella, G.; Canfora, F.; Caponio, V. C. A.; Mignogna, M. D.; Adamo, D.
Cross-Cultural Differences and Clinical Presentations in Burning Mouth Syndrome: A Cross-Sectional Comparative Study of Italian and Romanian Outpatient Settings
2025-01-01 Gabriel Ionescu, Claudiu; Musella, Gennaro; Canfora, Federica; D'Antonio, Cristina; Memé, Lucia; Leuci, Stefania; D'Aniello, Luca; Parlatescu, Ioanina; Lo Muzio, Lorenzo; Mignogna, Michele Davide; Tovaru, Serban; Adamo, Daniela
Early-Onset Oral Squamous Cell Carcinoma: Emerging Biological Insights, Risk Factors and Clinical Implications
2026-01-01 Musella, G.; D'Antonio, C.; Canfora, F.; Mignogna, M. D.; Vellone, V.; Caponio, V. C. A.; Giudice, A.; Villa, A.; Adamo, D.
Il ruolo dei radicali liberi nel determinismo del processo flogistico.
1991-01-01 Lo Muzio, L.; de Nigris, A.; Bucci, E. U.; Mignogna, R. E.; Mignogna, M. D.
Inside the Fire. Exploring the Impact of Anxiety, Depression, and Sleep Disturbances on Pain Perception in Burning Mouth Syndrome: A Cross-Sectional Study of 200 Patients
2025-01-01 Argiuolo, A.; Canfora, F.; Muzii, B.; D'Antonio, C.; D'Auria, D.; Giudice, A.; Musella, G.; D'Aniello, L.; Aria, M.; Maldonato, N. M.; Mignogna, M. D.; Adamo, D.
Knowledge, attitude and perception of Italian dental students toward HPV-related oropharyngeal cancer and vaccination: a cross-sectional study
2024-01-01 Musella, G.; Liguori, S.; Cantile, T.; Adamo, D.; Coppola, N.; Canfora, F.; Blasi, A.; Mignogna, M.; Amato, M.; Caponio, V. C. A.; Mignogna, M. D.; Leuci, S.
Le modifiche ambientali del cavo orale nel paziente geriatrico.
1992-01-01 Bucci, E.; Lo Muzio, L.; Mignogna, M. D.
Natural compounds may contribute in preventing SARS-CoV-2 infection: a narrative review
2022-01-01 Bizzoca, M. E.; Leuci, S.; Mignogna, M. D.; Muzio, E. L.; Caponio, V. C. A.; Muzio, L. L.
Oral Dysaesthetic and Perceptual Disorder, A Distinct Subset of Chronic Orofacial Pain Without Burning Symptoms: A Case–Control Study
2025-01-01 Musella, G.; Canfora, F.; Caponio, V. C. A.; Vardas, E.; Kouri, M.; Nikitakis, N.; Troiano, G.; Aria, M.; D'Aniello, L.; Lo Muzio, L.; Mignogna, M. D.; Adamo, D.
Oral mucosa and nails in genodermatoses: A diagnostic challenge
2021-01-01 Cantile, T.; Coppola, N.; Caponio, V. C. A.; Russo, D.; Bucci, P.; Spagnuolo, G.; Mignogna, M. D.; Leuci, S.
Response to “Burning mouth syndrome and oral dysaesthetic/perceptual symptoms: Toward clinically actionable boundaries”
2026-01-01 Musella, G.; Adamo, D.; Caponio, V. C. A.; Lo Muzio, L.; Mignogna, M. D.
Rethinking Burning Mouth Syndrome: Toward a multidimensional classification of oral dysaesthetic and perceptual disorders in ICHD-4
2026-01-01 Musella, G.; Adamo, D.; Caponio, V. C. A.; Lo Muzio, L.; Mignogna, M. D.
Salivary Calprotectin as a Biomarker in Early Onset Inflammatory Bowel Disease: A Pilot Study
2025-01-01 Liguori, S.; Musella, G.; Adamo, D.; Miele, E.; Coppola, N.; Canfora, F.; Del Giudice, C.; Spagnuolo, G.; Rengo, S.; Mignogna, M. D.; Leuci, S.
The Knowledge, Attitude, and Perception (KAP) of Healthcare Professionals in Pediatric Settings Toward Oral Manifestations of Inflammatory Bowel Disease (IBD): A Survey-Based Cross-Sectional Study
2026-01-01 Leuci, S.; Benvenuto, R.; Musella, G.; Liguori, S.; Marenzi, G.; Riccitiello, F.; Mignogna, M. D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Comment on “Toward ICHD-4: Proposing a broader diagnostic framework for burning mouth syndrome” by Suga et al., 2025 | 1-gen-2025 | Musella, G.; Canfora, F.; Caponio, V. C. A.; Mignogna, M. D.; Adamo, D. | |
| Cross-Cultural Differences and Clinical Presentations in Burning Mouth Syndrome: A Cross-Sectional Comparative Study of Italian and Romanian Outpatient Settings | 1-gen-2025 | Gabriel Ionescu, Claudiu; Musella, Gennaro; Canfora, Federica; D'Antonio, Cristina; Memé, Lucia; Leuci, Stefania; D'Aniello, Luca; Parlatescu, Ioanina; Lo Muzio, Lorenzo; Mignogna, Michele Davide; Tovaru, Serban; Adamo, Daniela | |
| Early-Onset Oral Squamous Cell Carcinoma: Emerging Biological Insights, Risk Factors and Clinical Implications | 1-gen-2026 | Musella, G.; D'Antonio, C.; Canfora, F.; Mignogna, M. D.; Vellone, V.; Caponio, V. C. A.; Giudice, A.; Villa, A.; Adamo, D. | |
| Il ruolo dei radicali liberi nel determinismo del processo flogistico. | 1-gen-1991 | Lo Muzio, L.; de Nigris, A.; Bucci, E. U.; Mignogna, R. E.; Mignogna, M. D. | |
| Inside the Fire. Exploring the Impact of Anxiety, Depression, and Sleep Disturbances on Pain Perception in Burning Mouth Syndrome: A Cross-Sectional Study of 200 Patients | 1-gen-2025 | Argiuolo, A.; Canfora, F.; Muzii, B.; D'Antonio, C.; D'Auria, D.; Giudice, A.; Musella, G.; D'Aniello, L.; Aria, M.; Maldonato, N. M.; Mignogna, M. D.; Adamo, D. | |
| Knowledge, attitude and perception of Italian dental students toward HPV-related oropharyngeal cancer and vaccination: a cross-sectional study | 1-gen-2024 | Musella, G.; Liguori, S.; Cantile, T.; Adamo, D.; Coppola, N.; Canfora, F.; Blasi, A.; Mignogna, M.; Amato, M.; Caponio, V. C. A.; Mignogna, M. D.; Leuci, S. | |
| Le modifiche ambientali del cavo orale nel paziente geriatrico. | 1-gen-1992 | Bucci, E.; Lo Muzio, L.; Mignogna, M. D. | |
| Natural compounds may contribute in preventing SARS-CoV-2 infection: a narrative review | 1-gen-2022 | Bizzoca, M. E.; Leuci, S.; Mignogna, M. D.; Muzio, E. L.; Caponio, V. C. A.; Muzio, L. L. | |
| Oral Dysaesthetic and Perceptual Disorder, A Distinct Subset of Chronic Orofacial Pain Without Burning Symptoms: A Case–Control Study | 1-gen-2025 | Musella, G.; Canfora, F.; Caponio, V. C. A.; Vardas, E.; Kouri, M.; Nikitakis, N.; Troiano, G.; Aria, M.; D'Aniello, L.; Lo Muzio, L.; Mignogna, M. D.; Adamo, D. | |
| Oral mucosa and nails in genodermatoses: A diagnostic challenge | 1-gen-2021 | Cantile, T.; Coppola, N.; Caponio, V. C. A.; Russo, D.; Bucci, P.; Spagnuolo, G.; Mignogna, M. D.; Leuci, S. | |
| Response to “Burning mouth syndrome and oral dysaesthetic/perceptual symptoms: Toward clinically actionable boundaries” | 1-gen-2026 | Musella, G.; Adamo, D.; Caponio, V. C. A.; Lo Muzio, L.; Mignogna, M. D. | |
| Rethinking Burning Mouth Syndrome: Toward a multidimensional classification of oral dysaesthetic and perceptual disorders in ICHD-4 | 1-gen-2026 | Musella, G.; Adamo, D.; Caponio, V. C. A.; Lo Muzio, L.; Mignogna, M. D. | |
| Salivary Calprotectin as a Biomarker in Early Onset Inflammatory Bowel Disease: A Pilot Study | 1-gen-2025 | Liguori, S.; Musella, G.; Adamo, D.; Miele, E.; Coppola, N.; Canfora, F.; Del Giudice, C.; Spagnuolo, G.; Rengo, S.; Mignogna, M. D.; Leuci, S. | |
| The Knowledge, Attitude, and Perception (KAP) of Healthcare Professionals in Pediatric Settings Toward Oral Manifestations of Inflammatory Bowel Disease (IBD): A Survey-Based Cross-Sectional Study | 1-gen-2026 | Leuci, S.; Benvenuto, R.; Musella, G.; Liguori, S.; Marenzi, G.; Riccitiello, F.; Mignogna, M. D. |